145
1.
Jegerlehner S, Bulliard JL, Aujesky D, Rodondi N, Germann S, Konzelmann I,
146
et al. Overdiagnosis and overtreatment of thyroid cancer: A population-based
147
temporal trend study. PloS one. 2017;12:e0179387.
148
2.
149
150
journal of otolaryngology. 1998;19:113-7.
3.
151
152
Hitchcock CL. The future of telepathology for the developing world. Archives of
pathology & laboratory medicine. 2011;135:211-4.
4.
153
154
Shaha AR, Jaffe BM. Parathyroid preservation during thyroid surgery. American
Aozasa K. Current status of the Japanese society of pathology with its 100th
anniversary. Japan Medical Association journal : JMAJ. 2012;55:416-8.
5.
Pelizzo MR, Losi A, Boschin IM, Toniato A, Pennelli G, Sorgato N, et al. Rapid
155
intraoperative parathyroid hormone assay in fine needle aspiration for
156
differential diagnosis in thyroid and parathyroid surgery. Clinical chemistry and
157
laboratory medicine. 2010;48:1313-7.
158
159
6.
Isono H, Shoumura S, Emura S. Ultrastructure of the parathyroid gland.
Histology and histopathology. 1990;5:95-112.
11
160
7.
161
162
Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current
concepts of cancer metabolism. Nature reviews Cancer. 2011;11:325-37.
8.
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg
163
effect: the metabolic requirements of cell proliferation. Science.
164
2009;324:1029-33.
165
9.
Mirebeau-Prunier D, Le Pennec S, Jacques C, Fontaine JF, Gueguen N,
166
Boutet-Bouzamondo N, et al. Estrogen-related receptor alpha modulates lactate
167
dehydrogenase activity in thyroid tumors. PloS one. 2013;8:e58683.
168
10.
169
170
cells in the metastatic frontier. Thyroid. 2011;21:487-92.
11.
171
172
173
Ringel MD. Metastatic dormancy and progression in thyroid cancer: targeting
Kendall CH, McCluskey E, Meagles JN. Oxyphil cells in thyroid disease: a
uniform change? J Clin Pathol. 1986;39:908-12.
12.
Katoh R, Harach HR, Williams ED. Solitary, multiple, and familial oxyphil
tumours of the thyroid gland. The Journal of pathology. 1998;186:292-9.
174
175
12
176
Figure legend
177
Scatterplot shows AST/LDH ratios in suspensions of various tissues, logarithmically
178
plotted on the graph. The median and standard deviation (SD) for each of the tissue
179
types are indicated at the bottom of the figure. Thyroid cancer: local recurrences,
180
metastatic lymph nodes and primary tumor; miscellaneous tissues: median cervical cyst,
181
connective tissue and thymus. Bold horizontal line: optimal threshold value to
182
distinguish parathyroid from other tissues (0.27). NA: not applicalble
183
13
184
Acknowledgment
185
We thank Marla Brunker, from Edanz Group (www.edanzediting.com/ac), for editing a
186
draft of this manuscript. This study has no funding to declare.
187
188
189
190
191
14
Table 1
Patient characteristics, surgical indications and specimen information.
Sex (M : F )
Age (mean, (range))
11:44
54y, (13-86)
Pathology of surgical indication
Papillary thyroid cancer
Follicular adenoma or hyperplasia
Follicular thyroid cancer
C-cell hyperplasia
Medullary thyroid cancer
Parathyroid cancer*
40
Parathyroid adenoma†
Total
55
Analyzed Specimens
Parathyroid
Papillary thyroid cancer
Primary tumor
Local recurrence
Metastatic lymph node
Follicular thyroid cancer
Local recurrence
Normal lymph node
Normal thyroid
Adipose tissue
Miscellaneous
Median cervical cyst
Connective tissue
Thymus
Total
43
14
13
10
94
Thyroid was measured.
Adipose tissue was measured.
Table 2.
Patients’ age, sex, tissue types, AST and LDH values (IU/L) and AST/LDH ratios in the tissue suspension
parathyroid
age sex
62 F
34 F
40 F
13 M
42 F
42 F
42 F
67 F
33 F
47 F
31 F
24 M
56 F
14 F
34 M 25 F
Surgical Indication
FTC
PTC
PTC
CCH
PTC
PTC
PTC
PTC
PTC
PTC
PTC
FA
PTC
PTC
PTC
FTC
AST (IU/L)
31
16
13
52
56
26
15
13
19
22
28
LDH (IU/L)
46
< 5†
20
25
129
157
94
10
43
46
< 5†
31
68
38
0.67
3.20
0.30
0.52
0.40
0.36
0.28
0.60
0.90
0.35
0.28
0.60
0.43
0.61
0.32
0.74
age sex
67 F
60 M
60 M
78 F
70 F
70 F
75 F
43 F
78 M
37 F
53 M
53 M
66 F
72 F
83 F 50 M
Surgical Indication
PTC
FA
FA
PTC
PTC
PTC
PTC
PTC
FA
PTC
PTC
PTC
PTC
PTC
PTC
PTC
AST (IU/L)
42
59
35
15
72
49
54
23
21
19
25
23
30
32
32
LDH (IU/L)
57
133
78
35
159
134
142
70
46
48
68
66
92
15
< 5†
99
0.74
0.44
0.45
0.43
0.45
0.37
0.38
0.33
0.46
0.40
0.37
0.35
0.33
0.27
6.40
0.32
age sex
38 F
14 M
65 F
65 F
77 F
77 F
47 F
47 F
47 F
47 F
56 F
Surgical Indication
PTC
MTC
PTC
PTC
PTC
PTC
FA
FA
FA
FA
PTC
AST (IU/L)
41
12
15
18
59
78
24
29
34
17
LDH (IU/L)
70
11
42
38
216
153
52
79
73
25
47
0.59
1.09
0.36
0.47
0.27
0.51
0.46
0.37
0.47
0.32
0.36
AST/LDH
parathyroid
AST/LDH
parathyroid
AST/LDH
thyroid cancer
age sex
58 F
74 M* 74 F*
42 F
74 F
source
L (FTC)
AST (IU/L)
30
LDH (IU/L)
AST/LDH
40
56
254
19
23
293
0.12
0.05
0.04
0.14
thyroid cancer
age sex
56 F*
source
M (FTC)
AST (IU/L)
11
LDH (IU/L)
46
142
88
0.11
0.08
0.02
AST/LDH
86 F* 60 M*
67 F* 77 F*
74 M
56 F
67 F
85 F* 60 F*
75 F
68 F* 38 F* 38 F*
< 1‡
34
95
14
29
87
23
13
774
10
21
174
268
1806
209
1593
583
204
234
378
0.07
0.10
0.10
0.05
0.13
0.05
0.07
0.02
0.15
0.11
0.04
0.03
normal lymph node
age sex
42 F
14 F*
14 F
14 F
14 F
70 F
75 F
43 F
43 F
73 F*
14 M
77 F
47 F
Surgical Indication
PTC
PTC
PTC
PTC
PTC
PTC
PTC
PTC
PTC
PTC
MTC
PTC
FA
AST (IU/L)
15
19
111
15
21
20
LDH (IU/L)
239
52
69
38
266
1836
218
103
135
236
126
274
AST/LDH
0.06
0.17
0.08
0.06
0.13
0.07
0.06
0.07
0.07
0.04
0.09
0.07
0.07
age sex
74 F
48 F
63 F
74 M
56 F
67F
78 F
53 F
50 M
38 F
Surgical Indication
PTC
FA
ParaA# PTC
PTC
PTC
FA
PTC
PTC
PTC
AST (IU/L)
48
17
LDH (IU/L)
140
32
39
58
75
231
95
49
27
101
AST/LDH
0.04
0.13
0.08
0.05
0.12
0.21
0.07
0.14
0.07
0.17
adipose tissue
normal thyroid
age sex
miscellaneous
40 F
Surgical Indication ParaC**
50 F*§ 50 Mǁ 14 M¶
42 F
56 F
47 F
78 F
47 F
PTC
PTC
FA
PTC
FA
PTC
PTC
MTC
AST (IU/L)
33
16
31
23
81
23
10
36
LDH (IU/L)
321
125
261
211
359
178
242
17
546
AST/LDH
0.10
0.13
0.12
0.11
0.23
0.13
0.04
0.06
0.07
All specimens of thyroid cancer were obtained from papillary thyroid cancers except for those indicated as follicular thyroid cancer
(FTC).
CCH: C-cell hyperplasia; FA: follicular adenoma or hyperplasia; L: local recurrence; M: metastatic lymph node; MTC: medullary thyroid
cancer; P: primary tumor; ParaA: parathyroid adenoma; ParaC: parathyroid cancer; PTC: papillary thyroid cancer.
* Specimen was obtained by preoperative fine needle aspiration biopsy.
† As concentration was below measurement limit (< 5 IU/L), 5 was used to calculate AST/LDH ratio.
‡ As concentration was below measurement limit (< 1 IU/L), 1 was used to calculate AST/LDH ratio.
§ Median cervical cyst
ǁ Connective tissue
¶ Thymus
# The AST/LDH ratio of this parathyroid adenoma was 0.63.
** The AST/LDH ratio of this parathyroid carcinoma was 0.21.
...